Subscribe
shutterstock_384310168_doro_guzenda
Doro Guzenda / Shutterstock.com
19 April 2022MedtechFran Salisbury and Alice Jefferies

Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Labour govt appoints new Minister with IP oversight
UK biotech aims at US rival over genome sequencing technology
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
Report reveals boom in digital health patents
Unified Patent Court: The cases, the numbers and what the future holds
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
Second chances: Brazil’s bid to revitalise the country’s healthcare system